The Rufaida Project: Researching the Impact of Ramadan Fasting on the Gut and Vaginal Microbiome
Rufaida
The Rufaida Project: Towards a Better Understanding of a Gut-vagina Axis by Investigating the Effects of Ramadan Fasting on Gut and Vaginal Microbial Communities
1 other identifier
observational
350
1 country
1
Brief Summary
The body's systems are deeply connected, but they are often studied separately. A recent large-scale citizen-science project on women's health, called Isala, discovered a group of gut-related bacteria present in the vaginal microbiome. This finding supports the idea that gut and vaginal bacteria interact closely, a connection known as the gut-vagina axis. However, it remains unclear whether changes in gut bacteria influence the vaginal microbiome. This discovery led to an exploration of how diet affects both the gut and vaginal microbiomes. In the gut, bacteria rely on carbohydrates from food, while in the vagina, bacteria feed on glycogen, a sugar stored in the vaginal lining. This glycogen is broken down into smaller sugars, which beneficial Lactobacillus bacteria use for fermentation. Since starch is a major source of these sugars, researchers suspect that a starch-rich diet may support Lactobacillus growth, which in turn promotes vaginal health. To test this hypothesis, the Rufaida Project was launched. Ramadan is characterised by a fasting period of approximately one month during which participants abstain from eating between sunrise and sunset. Ramadan provides a unique opportunity to study how fasting affects the microbiome under controlled conditions. In this study, 50 Muslim women will be asked to provide vaginal and stool samples at eight predetermined time points-before, during, and after Ramadan. These samples will be analysed using 16S rRNA amplicon sequencing to determine bacterial composition. Comparative analysis will be conducted between samples across different time points and anatomical sites. The objective is to understand how fasting and dietary changes influence the gut and vaginal microbiomes, and whether gut bacteria play a role in shaping vaginal health. Additionally, participants will complete weekly health questionnaires. An additional study group of up to 300 Muslim women will complete weekly questionnaires without providing biological samples. This research could improve understanding of the links between diet, gut health, and vaginal health, potentially leading to new strategies for enhancing women's well-being through nutrition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 4, 2025
CompletedFirst Submitted
Initial submission to the registry
March 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2025
CompletedFirst Posted
Study publicly available on registry
June 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedJune 3, 2025
February 1, 2025
4 months
March 25, 2025
May 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Characterizing the gut and vaginal microbiome in relation to dietary components and meal frequency during ramadan using 16S rRNA sequencing
To investigate the potential influence of dietary components and meal frequency on the gut and vaginal microbiome, vaginal and stool samples will be collected from participants before, during, and after a period of intermittent fasting (Ramadan). Bacterial community composition will be determined using 16S rRNA amplicon sequencing by Illumina MiSeq analysis. Bioinformatic tools will be employed to assess taxonomic profiles across different time points and anatomical sites. Particular attention will be given to correlations between gut- and vaginal-associated microbial taxa, with the aim of identifying bacterial signatures potentially shaped by dietary changes and fasting patterns. The analysis will further explore whether specific gut microbiota are associated with the presence or modulation of vaginal microbial communities, with a focus on health-promoting taxa such as Lactobacillus species.
up to 4 years
Secondary Outcomes (2)
Determining changes in psychological well-being during Ramadan through longitudinal questionnaires
Up to 4 years
Characterization of metabolite profiles in vaginal and stool samples before, during, and after Ramadan fasting
Up to 4 years
Study Arms (1)
Women participating in Ramadan
Healthy volunteers that plan on intermittent fasting during the month of Ramadan 2025. No food or drink will be consumed from sunrise until sundown
Eligibility Criteria
Healthy volunteers participating in Ramadan 2025 will be recruited through various channels. The selected women can join select to join group 1 (n=50) that take biological samples and fill out weekly questionnaires, or group 2 (n=300) that fill out weekly questionnaires.
You may qualify if:
- years or older on the moment of registration
- Female (biological gender)
- Currently living in Belgium
- Sufficient knowledge of the Dutch language
- Participating in Ramadan
- Has signed the informed consent
You may not qualify if:
- Breastfeeding at the start of and during the study
- Current diagnosis of cancer and/or immunosuppressive therapy in the six months before the study
- Cardiovascular and metabolic conditions (such as diabetes, irritable bowel syndrome, etc.)
- Clinically significant tendency to bleed throughout history;
- Clinically significant abnormalities of the reproductive organs;
- Use of oral/vaginal antibiotics/antimycotics in the 2 months prior to the study;
- Use of oral/vaginal pre-, pro-, and postbiotics (i.e., supplements in addition to diet) in the 2 weeks before and during the study;
- Ketogenic diet in the 2 weeks before and during the study;
- Vaginal douching during the study;
- Concurrent participation in another clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Antwerp
Antwerp, 2020, Belgium
Related Links
Biospecimen
Vaginal swabs with human and microbial DNA Stool swabs with human and microbial DNA Stool dry samples with human and microbial DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Lebeer, Professor
Universiteit Antwerpen
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2025
First Posted
June 3, 2025
Study Start
February 4, 2025
Primary Completion
May 30, 2025
Study Completion
February 1, 2026
Last Updated
June 3, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Following publication, the results associated with each study will also be deposited in the Dryad repository, where they will be preserved indefinitely. Sequences will be stored to ENA (public databases) and NCBI. All samples will be registered in the Biobank using the SLIMS system.
- Access Criteria
- A guide to data access on the EGA is available at https://ega-archive.org/access/data-access, and a data access request will be processed within 2-3 months, pending evaluation by the data access committee (existing of lab members involved in the study), and processing by the EGA.
The metadata of participants in the study will be made available in a restricted access repository. * For samples and data sharing, the researchers will work with the legal department to establish Material/Data Transfer Agreements. * Sequencing data are available at the European Nucleotide Archive. * Physical samples are their origin will be stored at the decentral hub of the Antwerp biobank. * Concerning non-identifiable sample meta-data that the researchers will use in analysis and will later be published will be put available with access control via the European Genome-Phenome Archive (EGA), where data can be accessed as described upon agreeing to the harmonized Data Access Agreement (developed by the European Union standards for in silico models for personalized medicine EU-STANDS4PM, https://doi.org/10.6084/m9.figshare.23904300).